Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine inpatient versus outpatient administration for complex regional pain syndrome
NL-OMON51901Recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of esketamine in complex regional pain syndrome (CRPS) (2 arms), sponsored by Erasmus MC. Primary endpoints: Average pain intensity over the last 24 hours and Current pain intensity. Started Feb 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NL-OMON51901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51901.